NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,335 | +1359.6% | 97,973 | +1503.2% | 0.05% | +2400.0% |
| Q2 2023 | $297 | -88.0% | 6,111 | -86.2% | 0.00% | -93.1% |
| Q1 2023 | $2,467 | +4.0% | 44,443 | -24.7% | 0.03% | 0.0% |
| Q4 2022 | $2,371 | -99.9% | 59,025 | -9.2% | 0.03% | +16.0% |
| Q2 2022 | $2,305,000 | +86.2% | 65,040 | +113.8% | 0.02% | +177.8% |
| Q1 2022 | $1,238,000 | +155.3% | 30,422 | +486.2% | 0.01% | +200.0% |
| Q4 2021 | $485,000 | +125.6% | 5,190 | +169.3% | 0.00% | +200.0% |
| Q3 2021 | $215,000 | -98.0% | 1,927 | -97.9% | 0.00% | -98.0% |
| Q2 2021 | $10,530,000 | +747.1% | 92,749 | +657.6% | 0.05% | +600.0% |
| Q1 2021 | $1,243,000 | -37.5% | 12,243 | -38.7% | 0.01% | -36.4% |
| Q4 2020 | $1,988,000 | +127.7% | 19,974 | +65.3% | 0.01% | +83.3% |
| Q3 2020 | $873,000 | -45.9% | 12,087 | -62.7% | 0.01% | -53.8% |
| Q2 2020 | $1,614,000 | +67.3% | 32,370 | +0.1% | 0.01% | +44.4% |
| Q1 2020 | $965,000 | +237.4% | 32,331 | +281.2% | 0.01% | +200.0% |
| Q4 2019 | $286,000 | -90.1% | 8,482 | -93.0% | 0.00% | -85.7% |
| Q3 2018 | $2,897,000 | +1984.2% | 121,020 | +947.6% | 0.02% | +2000.0% |
| Q2 2016 | $139,000 | – | 11,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |